EE200100396A - Eemaldatud geeniga BHV-1 viirust sisaldav vaktsiin - Google Patents
Eemaldatud geeniga BHV-1 viirust sisaldav vaktsiinInfo
- Publication number
- EE200100396A EE200100396A EEP200100396A EEP200100396A EE200100396A EE 200100396 A EE200100396 A EE 200100396A EE P200100396 A EEP200100396 A EE P200100396A EE P200100396 A EEP200100396 A EE P200100396A EE 200100396 A EE200100396 A EE 200100396A
- Authority
- EE
- Estonia
- Prior art keywords
- virus
- bhv
- deletion
- animals
- serves
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16741—Use of virus, viral particle or viral elements as a vector
- C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16761—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/240,173 US6284251B1 (en) | 1996-02-26 | 1999-01-29 | BHV-1 gene-deleted virus vaccine |
PCT/US2000/001085 WO2000044884A1 (en) | 1999-01-29 | 2000-01-18 | Bhv-1 gene-deleted virus vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200100396A true EE200100396A (et) | 2002-10-15 |
Family
ID=22905424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200100396A EE200100396A (et) | 1999-01-29 | 2000-01-18 | Eemaldatud geeniga BHV-1 viirust sisaldav vaktsiin |
Country Status (26)
Country | Link |
---|---|
US (1) | US6284251B1 (xx) |
EP (1) | EP1155119B1 (xx) |
JP (2) | JP2002535000A (xx) |
CN (1) | CN1197961C (xx) |
AT (1) | ATE342731T1 (xx) |
AU (1) | AU776261B2 (xx) |
BG (1) | BG105701A (xx) |
BR (1) | BR0007855A (xx) |
CA (1) | CA2359177C (xx) |
CZ (1) | CZ20012589A3 (xx) |
DE (1) | DE60031374T2 (xx) |
DK (1) | DK1155119T3 (xx) |
EA (1) | EA005736B1 (xx) |
EE (1) | EE200100396A (xx) |
ES (1) | ES2269101T3 (xx) |
HK (1) | HK1042512B (xx) |
HR (1) | HRP20010476B1 (xx) |
HU (1) | HUP0200560A2 (xx) |
NO (1) | NO20013697L (xx) |
NZ (1) | NZ512125A (xx) |
PT (1) | PT1155119E (xx) |
SK (1) | SK10702001A3 (xx) |
TR (1) | TR200102168T2 (xx) |
UA (1) | UA75035C2 (xx) |
WO (1) | WO2000044884A1 (xx) |
YU (1) | YU45601A (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2193842B1 (es) * | 2001-06-28 | 2005-06-01 | Consejo Superior De Investigaciones Cientificas | Virus recombinante de la fiebre aftosa que carece del sitio antigenico a y su utilizacion como vacuna marcada. |
CN101353670B (zh) * | 2007-07-27 | 2012-07-04 | 中国农业科学院哈尔滨兽医研究所 | 牛传染性鼻气管炎病毒重组毒株、其构建方法及应用 |
US8877211B2 (en) | 2011-06-27 | 2014-11-04 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Bovine herpes virus vaccine with multiple mutations |
CN104640991B (zh) * | 2012-07-04 | 2017-09-19 | 昆士兰州农渔林业部 | 重组低毒力1型牛疱疹病毒(BoHV‑1)疫苗载体 |
WO2016019244A1 (en) * | 2014-08-01 | 2016-02-04 | Chowdhury Shafiqul I | Bovine herpesvirus detection and treatment |
CN107893056B (zh) * | 2017-12-13 | 2019-08-27 | 江苏省农业科学院 | 山羊疱疹病毒ⅰ型疫苗株及其应用 |
CN108690835B (zh) * | 2018-05-30 | 2021-08-31 | 内蒙古元山生物科技有限公司 | 一株I型牛疱疹病毒gE缺失毒株及其获取方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8305323D0 (en) | 1983-02-25 | 1983-03-30 | Baylor College Medicine | Infectious bovine rhinotracheitis vaccine |
EP0231209B1 (en) | 1985-07-29 | 1991-02-06 | The Upjohn Company | Virus vaccine |
US4703011A (en) | 1985-11-12 | 1987-10-27 | Novagene, Inc. | Thymidine kinase deletion mutants of bovine herpesvirus-1 |
US5593873A (en) * | 1986-01-27 | 1997-01-14 | Syntro Corporation | Recombinant infectious bovine rhinotracheitis virus |
AU3579089A (en) | 1988-05-03 | 1989-11-29 | Upjohn Company, The | Glycoprotein h of herpes viruses |
FR2693472B1 (fr) | 1992-06-26 | 1994-12-23 | Rhone Merieux | Mutants du virus de la rhinotrachéite infectieuse bovine, délétés dans l'un des gènes des glycoprotéines mineures, vaccins préparés à partir de ces souches, méthodes de production et méthodes d'utilisation. |
NL9100989A (nl) | 1991-06-07 | 1993-01-04 | Stichting Centr Diergeneeskund | Bovine herpesvirus type 1 deletiemutanten, daarop gebaseerde vaccins, diagnostische kits voor detectie van bovine herpesvirus type 1. |
CA2113641A1 (en) | 1991-07-18 | 1993-02-04 | Mark D. Cochran | Recombinant infectious bovine rhinotracheitis virus |
US5874279A (en) * | 1991-07-18 | 1999-02-23 | Syntro Corporation | Recombinant infectious bovine rhinotracheitis virus |
CA2057387A1 (en) | 1991-12-11 | 1993-06-12 | Lorne A. Babiuk | Recombinant bovine herpesvirus type 1 polypeptides and vaccines |
ES2074965B1 (es) * | 1994-01-31 | 1996-05-01 | Hipra Lab Sa | Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen. |
-
1999
- 1999-01-29 US US09/240,173 patent/US6284251B1/en not_active Expired - Fee Related
-
2000
- 2000-01-18 UA UA2001075409A patent/UA75035C2/uk unknown
- 2000-01-18 DE DE60031374T patent/DE60031374T2/de not_active Expired - Fee Related
- 2000-01-18 SK SK1070-2001A patent/SK10702001A3/sk unknown
- 2000-01-18 YU YU45601A patent/YU45601A/sh unknown
- 2000-01-18 CA CA002359177A patent/CA2359177C/en not_active Expired - Fee Related
- 2000-01-18 DK DK00904385T patent/DK1155119T3/da active
- 2000-01-18 HU HU0200560A patent/HUP0200560A2/hu unknown
- 2000-01-18 EA EA200100720A patent/EA005736B1/ru not_active IP Right Cessation
- 2000-01-18 WO PCT/US2000/001085 patent/WO2000044884A1/en active IP Right Grant
- 2000-01-18 BR BR0007855-7A patent/BR0007855A/pt not_active IP Right Cessation
- 2000-01-18 PT PT00904385T patent/PT1155119E/pt unknown
- 2000-01-18 CZ CZ20012589A patent/CZ20012589A3/cs unknown
- 2000-01-18 NZ NZ512125A patent/NZ512125A/xx unknown
- 2000-01-18 AU AU26152/00A patent/AU776261B2/en not_active Ceased
- 2000-01-18 EE EEP200100396A patent/EE200100396A/xx unknown
- 2000-01-18 AT AT00904385T patent/ATE342731T1/de not_active IP Right Cessation
- 2000-01-18 EP EP00904385A patent/EP1155119B1/en not_active Expired - Lifetime
- 2000-01-18 JP JP2000596128A patent/JP2002535000A/ja active Pending
- 2000-01-18 CN CNB008031363A patent/CN1197961C/zh not_active Expired - Fee Related
- 2000-01-18 TR TR2001/02168T patent/TR200102168T2/xx unknown
- 2000-01-18 ES ES00904385T patent/ES2269101T3/es not_active Expired - Lifetime
-
2001
- 2001-06-25 HR HR20010476A patent/HRP20010476B1/xx not_active IP Right Cessation
- 2001-07-12 BG BG105701A patent/BG105701A/bg unknown
- 2001-07-27 NO NO20013697A patent/NO20013697L/no not_active Application Discontinuation
-
2002
- 2002-03-25 HK HK02102265.2A patent/HK1042512B/zh not_active IP Right Cessation
-
2006
- 2006-08-23 JP JP2006226616A patent/JP2007020574A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU585126B2 (en) | Recombinant herpes simplex viruses, vaccines and methods | |
DE69535359D1 (de) | Rekombinantes herpesvirus aus trufhähnen und seine verwendungen | |
ZA865277B (en) | Virus vaccine | |
AUPO856097A0 (en) | Vector | |
AU6489986A (en) | Thymidine kinase deletion mutants of bovine herpersvirus-1, vaccines against infectious bovine rhinotracheitis containing same and methods for the production and use of same | |
NZ228409A (en) | Marek's disease virus used as a multifunctional live vaccine | |
EE200100396A (et) | Eemaldatud geeniga BHV-1 viirust sisaldav vaktsiin | |
AU2403188A (en) | Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same | |
WO1994000586A3 (fr) | Mutants et vaccins du virus de la rhinotracheite infectieuse bovine | |
WO2004009763A3 (en) | Use of vaccinia virus deleted for the e3l gene as a vaccine vector | |
IL141443A0 (en) | Vaccine comprising cytokine-induced heat shock proteins (hsp) | |
DK0606452T3 (da) | Vektorvacciner fra rekombinant katteherpesvirus | |
Chowdhury | BHV-1 gene-deleted virus vaccine | |
ES2074965A1 (es) | Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen. | |
EP1074624A4 (en) | GENE 62 OF THE ATTENUATED VARICELLA VIRUS STRAIN OKA AND METHOD FOR IDENTIFYING THE VIRUS STRAIN ATTENUATED VARICELLA VACCINE USING THE SAME | |
Audonnet et al. | Avian herpesvirus-based live recombinant avian vaccine, in particular against Gumboro disease |